ABP-700

DB15411InvestigationalSmall molecule

ABP-700 is under investigation in clinical trial NCT02800590 (Study to Investigate the Safety and Efficacy of 3 Dosing Regimens of ABP-700 for Procedural Sedation in Adult Participants Undergoing Colonoscopy).

Mechanism: Pharmacologically active on GABA(A) Receptor
Curator reviewed
Formula / weight: C₁₇H₁₈N₂O₄ · 314.341 g/mol (avg)
Code names: ABP-700

Resolves to

Compound

UNIILZ0835OW2MCAS1446482-29-6

Structure

InChIKeyDRAFVCKNYNQOKR-GFCCVEGCSA-NSMILESCOC(=O)C1(CC1)OC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which companies are running trials of ABP-700, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account